E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease
返回论文页
Full-length article|更新时间:2024-02-04
|
E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease
Genes & DiseasesVol. 11, Issue 2, (2024)
作者机构:
1. Department of Neurology, Renmin Hospital of Wuhan University,Hubei,Wuhan,China,430060
2. Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,China,200025
3. Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University,Fujian,Xiamen,China,361102
4. Department of Medicinal Chemistry, School of Pharmacy, Fudan University,Shanghai,China,201203
5. Shenzhen Research Institute of Xiamen University,Guangdong,Shenzhen,China,518063
6. Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine,Shanghai,China,200025
Yongfang Zhang, Xinyi Xie, Boyu Chen, et al. E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease. [J]. Genes & Diseases 11(2).(2024)
DOI:
Yongfang Zhang, Xinyi Xie, Boyu Chen, et al. E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease. [J]. Genes & Diseases 11(2).(2024) DOI: 10.1016/j.gendis.2023.02.051.
E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease
摘要
Abstract
Identified as the pathogenic genes of Alzheimer's disease (AD)
APP
PSEN1
and PSEN2
mainly lead to early-onset AD
whose course is more aggressive
and atypical symptoms are more common than sporadic AD. Here
a novel missense mutation
APP
E674Q (also named “Shanghai
APP
”)
was detected in a Chinese index patient with typical late-onset AD (LOAD) who developed memory decline in his mid-70s. The results from neuroimaging were consistent with AD
where widespread amyloid β deposition was demonstrated in
18
F-florbetapir Positron Emission Tomography (PET).
APP
E674Q is close to the β-secretase cleavage site and the well-studied Swedish
APP
mutation (KM670/671NL)
which was predicted to be pathogenic
in silico
. Molecular dynamics simulation indicated that the E674Q mutation resulted in a rearrangement of the interaction mode between APP and BACE1 and that the E674Q mutation was more prone to cleavage by BACE1. The
in vitro
results suggested that the E674Q mutation was pathogenic by facilitating the BACE1-mediated processing of APP and the production of Aβ. Furthermore
we applied an adeno-associated virus (AAV)-mediated transfer of the human E674Q mutant APP gene to the hippocampi of two-month-old C57Bl/6 J mice. AAV-E674Q-injected mice exhibited impaired learning behavior and increased pathological burden in the brain
implying that the E674Q mutation had a pathogenicity that bore a comparison with the classical Swedish mutation. Collectively
we report a strong amyloidogenic effect of the E674Q substitution in AD. To our knowledge
E674Q is the only pathogenic mutation within the amyloid processing sequence causing LOAD.
Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer's disease
Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study
Estrogen deficiency exacerbates learning and memory deficits associated with glucose metabolism disorder in APP/PS1 double transgenic female mice
Ubiquitination status does not affect Vps34 degradation
Related Author
Waqar Ahmad
Paul R. Ebert
Gang Wang
Ru-Jing Ren
Sheng-di Chen
Eric Dammer
Qiang Huang
Qian-Hua Zhao
Related Institution
School of Biological Sciences, The University of Queensland
Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine
Institute of Neurology, Huashan Hospital, Fudan University
National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University
Department of Biochemistry, Center for Neurodegenerative Disease, Emory University School of Medicine